To better understand the possible mechanism by which METTL3 participates in HR+HER2− BC progression, we first performed DEG analysis of the GSE87455 and GSE763 data sets and identified 4049 and 1783 DEGs in these two cohorts, respectively. The gene discussed is METTL3; the disease is breast cancer.